Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-676x|7|2|120-124

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.7, Iss.2, 2011-05, pp. : 120-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Mechanism of Deguelin in Anti-tumor Effect

By  

Current Pharmaceutical Analysis, Vol. 8, Iss. 1, 2012-02 ,pp. : 14-19

Bentham Science Publishers

Access to resources Recommend Favorite

Oridonin, a Promising Antitumor Natural Product in the Chemotherapy of Hematological Malignancies

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 11, 2014-11 ,pp. : 1083-1092

Bentham Science Publishers

Access to resources Recommend Favorite

Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile

By  

Current Pharmaceutical Design, Vol. 22, Iss. 28, 2016-09 ,pp. : 4386-4397

Bentham Science Publishers

Access to resources Recommend Favorite

Bortezomib: Proteasome Inhibition as a Novel Mechanism of Cancer Therapy-Implications for Hematological Malignancies

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 82-86

Bentham Science Publishers

Access to resources Recommend Favorite

Counterpoint: Routine Anti-Bacterial Prophylaxis Is Not Indicated in Neutropenic Patients With Hematological Malignancies

By Kleinberg Michael  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 5, 2004-09 ,pp. : 445-451

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite